130 related articles for article (PubMed ID: 37706110)
1. Hepatocellular Carcinoma and Hepatitis Delta Virus.
Reau NS
Gastroenterol Hepatol (N Y); 2023 Mar; 19(3):155-157. PubMed ID: 37706110
[No Abstract] [Full Text] [Related]
2. Hepatitis viruses (other than hepatitis B and C viruses) as causes of hepatocellular carcinoma: an update.
Kew MC
J Viral Hepat; 2013 Mar; 20(3):149-57. PubMed ID: 23383653
[TBL] [Abstract][Full Text] [Related]
3. LIVER TRANSPLANTATION IN HEPATITIS DELTA: SOUTH AMERICA EXPERIENCE.
Lima DS; Murad Júnior AJ; Barreira MA; Fernandes GC; Coelho GR; Garcia JHP
Arq Gastroenterol; 2018; 55(1):14-17. PubMed ID: 29561969
[TBL] [Abstract][Full Text] [Related]
4. Comparison of clinico-pathological features in hepatitis B virus-associated hepatocellular carcinoma with or without hepatitis D virus superinfection.
Huo TI; Wu JC; Lai CR; Lu CL; Sheng WY; Lee SD
J Hepatol; 1996 Oct; 25(4):439-44. PubMed ID: 8912142
[TBL] [Abstract][Full Text] [Related]
5. Delta agent infection in patients with chronic liver diseases and hepatocellular carcinoma--an infrequent finding in Taiwan.
Chen DS; Lai MY; Sung JL
Hepatology; 1984; 4(3):502-3. PubMed ID: 6327488
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis delta virus and hepatocellular carcinoma: an update.
Romeo R; Petruzziello A; Pecheur EI; Facchetti F; Perbellini R; Galmozzi E; Khan NU; Di Capua L; Sabatino R; Botti G; Loquercio G
Epidemiol Infect; 2018 Oct; 146(13):1612-1618. PubMed ID: 29991359
[TBL] [Abstract][Full Text] [Related]
7. General evaluation of hepatectomy and hepatocellular carcinoma cases.
Başsüllü N; Türkmen I; Yaprak O; Dayangaç M; Demırbaş T; Güler N; Uraz S; Akyildiz M; Cığercıoğullari E; Tokat Y; Yüzer Y; Doğusoy GB
Turk Patoloji Derg; 2011; 27(3):221-9. PubMed ID: 21935872
[TBL] [Abstract][Full Text] [Related]
8. Proteomic changes in HEK-293 cells induced by hepatitis delta virus replication.
Mendes M; Pérez-Hernandez D; Vázquez J; Coelho AV; Cunha C
J Proteomics; 2013 Aug; 89():24-38. PubMed ID: 23770296
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy for hepatocellular carcinoma in a patient with hepatitis B virus and hepatitis delta virus coinfection.
Jachs M; Scheiner B; Pinter M
J Hepatol; 2022 Jul; 77(1):256-257. PubMed ID: 35124108
[No Abstract] [Full Text] [Related]
10. Molecular biology of viral hepatitis and hepatocellular carcinoma.
Hayashi PH; Zeldis JB
Compr Ther; 1993; 19(5):188-96. PubMed ID: 8275664
[TBL] [Abstract][Full Text] [Related]
11. Incidence of hepatitis D virus infection in Japanese patients with hepatocellular carcinoma--immunohistochemical investigation of the delta antigen.
Kage M; Kosai K; Shimamatsu K; Nakashima O; Haramaki M; Yasunaga M; Iha H; Kojiro M; Govindarajan S
Kurume Med J; 1992; 39(4):231-4. PubMed ID: 1339069
[TBL] [Abstract][Full Text] [Related]
12. A Case Report of Hepatocellular Carcinoma 5 Years After HBsAg Loss in Chronic Hepatitis Delta: How Long Surveillance is Required?
Escolà-Vergé L; Riveiro-Barciela M; Buti M
Ann Hepatol; 2017; 16(4):630-632. PubMed ID: 28611272
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of delta antigen/antibody in B-viral-associated hepatocellular carcinoma.
Govindarajan S; Hevia FJ; Peters RL
Cancer; 1984 Apr; 53(8):1692-4. PubMed ID: 6321013
[TBL] [Abstract][Full Text] [Related]
14. [Delta virus infection in hemodialyzed kidney patients and patients with chronic liver diseases].
Ibrányi E; Mihály I; Kovács M; Telegdy L
Orv Hetil; 1992 Jul; 133 Suppl 1():45-8. PubMed ID: 1321398
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B/D-Related Hepatocellular Carcinoma. A Clinical Literature Review.
Baskiran A; Atay A; Baskiran DY; Akbulut S
J Gastrointest Cancer; 2021 Dec; 52(4):1192-1197. PubMed ID: 34611832
[TBL] [Abstract][Full Text] [Related]
16. [Hepatitis delta virus replication and the role of the small hepatitis delta protein S-HDAg].
Abeywickrama-Samarakoon N; Cortay JC; Sureau C; Alfaiate D; Levrero M; Dény P
Med Sci (Paris); 2018 Oct; 34(10):833-841. PubMed ID: 30451678
[TBL] [Abstract][Full Text] [Related]
17. [Delta hepatitis: Epidemiology, diagnostic, natural history and treatment].
Loureiro D; Castelnau C; Bed CM; Asselah T
Rev Med Interne; 2022 Mar; 43(3):160-169. PubMed ID: 34799189
[TBL] [Abstract][Full Text] [Related]
18. [The return of the hepatitis delta virus].
Zoutendijk R; de Jonge PJ; de Man RA
Ned Tijdschr Geneeskd; 2016; 160():D70. PubMed ID: 27405575
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of antibodies to hepatitis C virus in patients with hepatocellular carcinoma in Austria.
Baur M; Hay U; Novacek G; Dittrich C; Ferenci P
Arch Virol Suppl; 1992; 4():76-80. PubMed ID: 1280509
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis delta virus (HDV) infection and hepatocellular carcinoma (HCC).
Oliveri F; Brunetto MR; Baldi M; Piantino P; Ponzetto A; Forzani B; Smedile A; Verme G; Bonino F
Prog Clin Biol Res; 1991; 364():217-22. PubMed ID: 1850527
[No Abstract] [Full Text] [Related]
[Next] [New Search]
